New diabetes clinical trial: A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Published on: February 28, 2022 at 10:30PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: IcoSema;   Drug: Semaglutide 1 mg
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/nxbq3vX